Until recently, adenovirus-based gene therapy has been almost exclusively based on human adenovirus serotype 5 (Ad5). The aim of this study was to systematically compare the efficiency of transduction of primary muscle cells from various species by two adenoviral vectors from subgroups C and D. Transduction of a panel of myoblasts demonstrated a striking specificity of an Ad19a-based replication-defective E1-deleted vector (Ad19aEGFP) for human cells, whereas the Ad5-based vector had high affinity for nonhuman primate myoblasts. Transgene expression correlated well with cell-associated vector genomes. Up to 6.59% of the initially applied Ad19aEGFP vector particles were taken up by human myoblasts, as compared with 0.1% of the corresponding Ad5 vector. Remarkably, Ad19aEGFP but not Ad5EGFP efficiently transduced differentiated human myotubes, an in vitro model for skeletal muscle transduction. Uptake of Ad19aEGFP vector particles in human myotubes was 12-fold more efficient than that of Ad5EGFP. Moreover, both vectors demonstrated an early block at the level of vector uptake in mouse myoblasts and rat L6 cells. Investigation of the underlying mechanism for binding and uptake of the two vectors by human myoblasts showed high susceptibility for Ad19a to neuraminidase and wheat germ agglutinin (WGA) lectin, whereas Ad5-mediated transduction was dependent on binding to the coxsackie-adenovirus receptor (CAR) and sensitive to soluble RGD peptide and heparin. Our study offers insights into species-dependent factors that determine Ad tropism and, moreover, provides a basis for application of the novel Ad19a-based vector for gene transfer into human skeletal muscle.
INTRODUCTION T
O DATE, 51 HUMAN ADENOVIRUS SEROTYPES have been identified and classified into six subgroups (A to F) (De Jong et al., 1999) . Subgroup C adenoviruses include the most extensively studied serotypes Ad2 and Ad5, which are widely used as gene transfer vectors. These adenoviruses use separate cellular receptors for attachment and entry. Ad5 binds with high affinity to the 46-kDa coxsackie-adenovirus receptor (CAR), whereas virus internalization is mediated primarily by interaction of the penton base protein with ␣ v integrins (Wickham et al., 1993; Bergelson et al., 1997; Tomko et al., 1997) . Apart from subgroup C adenoviruses and type B coxsackieviruses, human adenovirus serotypes from subgroups A, D, E, and F, as well as adenoviruses from other species, such as the avian adenovirus CELO and the chimpanzee AdCV-68, may use CAR as the attachment receptor (Roelvink et al., 1998; Tan et al., 2001; Cohen et al., 2002) . Subgroup B adenoviruses use CD46 as the cellular attachment receptor (Gaggar et al., 2003; Segerman et al., 2003) , whereas for subgroup D adenoviruses with ocular tropism (e.g., Ad37) the receptor issue is controversial. On the one hand, it was shown that these adenoviruses bind to a 50-kDa protein, identified as CD46 (Wu et al., 2001 (Wu et al., , 2004 ; on the other hand, these viruses were reported to use sialic acid-containing receptors (Arnberg et al., 2000a,b) .
A major limitation of the use of Ad5 vectors is that many human cell types and tissues are refractory to Ad5 infection. As demonstrated recently, non-Ad5 vectors may overcome this limitation: E1-deleted vectors based on serotypes 35 and 11 efficiently transduced human dendritic cells and CD34 ϩ hematopoietic progenitor cells and were able to bypass preexisting adenovirus immunity in vivo (Vogels et al., 2003; Stone et al., 2005) . Preexisting anti-adenovirus immunity is another hurdle for adenovirus gene therapy, preventing vector readministration. In humans the extent of the humoral response is dependent on preexisting antibody titers and the route of administration (Harvey et al., 1999; Chen et al., 2000) . Diminished transgene expression after a second vector application was overcome by switching to another adenovirus serotype even within the same subgroup (Mastrangeli et al., 1996; Morral et al., 1999) . With helper-dependent vectors the problem of diminished transgene expression after repeated vector administration could also be overcome by switching the serotype with the second injection . Low efficiency of transduction of skeletal muscle in vivo is a major hurdle for muscle-directed gene therapy (Huard et al., 1995; Bilbao et al., 2003) . The efficiency of transduction of myofibers in animal models of muscular dystrophy of different ages was shown to be dependent on the maturation state of the muscle. Whereas skeletal muscle fibers of newborn mice were efficiently transduced in a CAR-dependent way by Ad5-based vectors, mature muscle fibers of adult mice were significantly less transduced (Huard et al., 1995; Bilbao et al., 2003) . This maturation-dependent decrease in muscle transduction is mirrored in vitro by a similar decrease in transduction of differentiated myotubes as compared with myoblasts (Acsadi et al., 1994) . The observed high adenoviral transduction efficiency in newborn myofibers may be due partly to transduction of myoblasts (Feero et al., 1997) , and partly to higher expression of CAR in these myofibers (Nalbantoglu et al., 1999) .
In this study we show that, in contrast to Ad5, a novel replication-deficient Ad19a vector belonging to subgroup D efficiently transduced primary human myoblasts as well as myotubes. We compared transduction efficiencies of both vectors for primary muscle cells originating from different species by means of real-time polymerase chain reaction (Q-PCR), fluorescence-activated cell-sorting (FACS) analysis, and transgene expression. Both vectors displayed a species-dependent transduction pattern. We further demonstrate that attachment of Ad19a to primary human myoblasts occurred through a glycoepitope and was dependent mainly on ␣(2,3)-linked sialic acid-containing receptors, whereas attachment of the Ad5 vector was more complex and involved binding to heparan sulfate proteoglycans. In conclusion, the novel Ad19a vector displayed human muscle cell tropism in vitro, using a entry mechanism different from that used by Ad5, and may thus be a good candidate virus for human muscle transduction in vivo.
MATERIALS AND METHODS

Culture conditions of cell lines and primary cells
293A cells and rat L6 myoblasts were grown in Dulbecco's modified Eagle's medium (DMEM) supplemented with 10% fetal calf serum (FCS) (Invitrogen Life Technologies, Karlsruhe, Germany). N52.E6 cells were grown in ␣-MEM (Invitrogen Life Technologies) supplemented with 10% FCS, 2 mM glutamine, and 1% penicillin-streptomycin. Fetal human myoblasts (FHMs), ape myoblasts from an 8-year-old rhesus monkey (Macaca mulatta), fetal pig myoblasts, and mouse (BALB/c) myoblasts were obtained from the Muscle Tissue Culture Collection (MTCC, Friedrich Baur Institut, Munich, Germany). Human, ape, and pig myoblasts were grown in skeletal muscle cell growth medium (Promocell, Heidelberg, Germany), and primary mouse myoblasts were grown in DMEM supplemented with 20% FCS and 2 mM glutamine (Invitrogen Life Technologies). Multinucleated myotubes were obtained after fusion of human or ape myoblasts for 10 days in serum-reduced fusion medium (DMEM supplemented with 2% horse serum and 2 mM glutamine). Myoblasts were seeded at 1.5 ϫ 10 4 per well (48-well plate) and fusion was induced at 70% confluence. All cells were grown in a humidified atmosphere with 5% CO 2 at 37°C.
Enrichment of myoblasts by magnetic cell sorting
Primary human myoblasts were separated from coisolated fibroblasts by magnetic affinity cell sorting (MACS). Myoblasts (~1 ϫ 10 6 cells per dish) were cultured on 10-cm dishes and harvested by limited treatment with 0.25% trypsin and 1 mM EDTA (Sigma, Deisenhofen, Germany) at 37°C. Enrichment of human myoblasts, which express the differentiation antigen NCAM (neuronal cell adhesion molecule), was achieved by MACS using a human monoclonal antibody 5.1H11 directed against NCAM (Walsh and Ritter, 1981) . Subsequent MACS purification was done according to the manufacturer's recommendations.
Adenoviral vectors
Ad19aEGFP is a novel E1, E3-deleted first-generation adenovirus vector based on the Ad19a serotype (Wadell and De Jong, 1980; Wadell, 1984) . Ad19a (strain ME), originally described as a genome type of Ad19p, is associated with epidemic keratoconjunctivitis, whereas the Ad19p prototype is not. Sequence analysis suggests that Ad19a may originate from a recombination event between Ad37 and an Ad19p-like virus (Blusch et al., 2002; Windheim and Burgert, 2002) . The vector contains an enhanced green fluorescent protein (EGFP) expression cassette inserted into the E1 region between nucleotides 421 and 3300, consisting of the EGFP open reading frame under the control of the human cytomegalovirus (hCMV) promoter, a simian virus 40 (SV40) poly(A) region at the 3Ј end in a left-to-right orientation, followed by the SV40 enhancer (Ruzsics et al., manuscript in preparation) . The first-generation E1-deleted vector Ad5EGFP was generated by insertion of a blunted AflIII-AflII fragment from pEGFP-N1 (Clontech, Heidelberg, Germany) into the blunted PacI site of pGS66 (Schiedner et al., 2000) . As for Ad19aEGFP, the plasmid pAd5EGFP contains the EGFP open reading frame inserted into the E1 region in a left-to-right orientation under the control of the hCMV promoter and followed by an SV40 poly(A) region at the 3Ј end. The Ad5EGFP reporter vector was rescued as previously described by the calcium phosphate method and propagated on N52.E6 cells (Hitt et al., 1998; Schiedner et al., 2000) . AdFZ␤Gal is a first-generation vector expressing ␤-galactosidase (Biermann et al., 2001) .
Titration of adenoviral vectors
We used quantitative PCR (Q-PCR) as previously described for genomic titration of adenovirus vectors (Ma et al., 2001) . Infectious particles were determined as gene transduction units (GTU) by limiting vector dilution and quantification of GFPexpressing 293 cells (Mittereder et al., 1996) . Vector preparations were purified by CsCl density gradient centrifugation. Quantitative real-time PCR was done with a real-time fluorescence detection ABI PRISM 7000 sequence detector (Applied Biosystems, Foster City, CA) and SYBR Green as a doublestranded DNA-specific fluorescent dye (Applied Biosystems). Serial dilutions of plasmid pEGFP-N1 (Clontech) were prepared to obtain a standard calibration curve (C t values versus plasmid copy numbers). The equation of the linear regressed curve was y ϭ Ϫ3.2369x ϩ 35.005 with a correlation coefficient of R 2 ϭ 0.9987 and a reaction efficiency of 1.04. The particle titer for Ad5EGFP was 4.623 ϫ 10 11 viral particles (VP)/ml, and 4.589 ϫ 10 11 VP/ml for Ad19aEGFP. Determination of gene transfer units (fluorescence-forming units [FFU] ) on 293 cells yielded 5.07 ϫ 10 9 FFU/ml for Ad5EGFP and 7.23 ϫ 10 9 FFU/ml for Ad19aEGFP. To determine the amount of cell-associated vector genomes in transduced cells, total cellular DNA was purified from transduced cells with a QIAamp genomic DNA purification kit (Qiagen, Hilden, Germany) and used directly as template for the Q-PCR.
Adenovirus transduction assays
Two days before transduction primary myoblasts were seeded at 1 ϫ 10 4 cells per well in 48-well flat-bottom tissue culture plates (Corning Life Sciences, Acton, MA), and grown to subconfluence. Cells in three control wells were detached and counted before each experiment. For transduction 1250, 2500, or 12,500 VP/cell was added per well and cells were incubated for 16 hr at 37°C in DMEM containing 2% FCS. Thereafter the cells were washed once with phosphate-buffered saline (PBS) and further incubated in growth medium supplemented with 10% FCS at 37°C for a total of 48 hr until transgene expression was measured. Myotubes were transduced and cultured in fusion medium until measurement of transgene expression. Pictures of fluorescent cells were recorded at 48 hr with an AxioCam HRc on a Leica DMRBE epifluorescence microscope and analyzed with AxioVision 3.1 software (Zeiss, Jena, Germany).
Vector competition assays
Cells were preincubated for 1 hr at 4°C with inhibiting reagents in transduction medium (OptiMEM I medium supplemented with 2% serum; Invitrogen Life Technologies). Cells were transduced with 20 GTU/cell (multiplicity of infection [MOI] , 20) for 1 hr on ice in the presence of recombinant knob proteins (Ad19a: 10 or 100 g/ml; Ad5: 10 g/ml), 2 mM GRGDS peptide (Sigma), heparin (10 g/ml; Sigma), wheat germ agglutinin (50 g/ml; Sigma), or combinations thereof. Treatment with ␣(2,3)-neuraminidase (New England BioLabs, Beverly, MA) was done for 1 hr at 37°C before addition of vectors. For competition of vector internalization, cells were incubated with the respective inhibiting agents for 1 hr at 4°C followed by transduction with vector (MOI, 20) for 1 hr at 37°C. Cells were washed once with transduction medium and further incubated for 48 hr in growth medium at 37°C until transgene expression was measured.
Quantification of transgene expression
Transgene expression in cells transduced with Ad5EGFP or Ad19aEGFP was measured with a fluorescence multiwell plate reader (Applied Biosystems). Transgene expression in cells transduced with vectors expressing ␤-galactosidase (AdFZ␤-Gal was evaluated by luminometric quantitation of ␤-galactosidase activity. For luminometric quantitation of ␤-galactosidase activity the total amount of cell protein was determined with the Micro BCA protein assay (Pierce Biotechnology, Rockford, IL) and equal amounts of protein incubated with Galacto-Star reagent (Applied Biosystems) according to the manufacturer's instructions. Light emission was measured with a Berthold plate luminometer (Berthold Technologies, Bad Wildbad, Germany).
Flow cytometry: FACS
Cells were detached from the cell culture dishes by trypsinization, washed three times with PBS, and fixed for 30 min at room temperature in PBS containing 1% paraformaldehyde (PFA). Next, the cells were resuspended in 500 l of PBS containing 1% fetal bovine serum (FBS) supplemented with 0.01% NaN 3 and analyzed for GFP expression with a FACScan cytometer (BD Biosciences, Heidelberg, Germany). The number of total events per experiment collected was 10,000.
Cloning, expression, and purification of recombinant proteins
The Ad19a knob expression plasmid pTrcK19a was generated by PCR amplification of the fiber gene region encompassing the Ad19a knob domain, using primers containing nonhybridizing BamHI and EcoRI restriction sites at their 5Ј ends (Knob19aF, 5Ј-ATATGGATCCAGTAAGAGCAAGAGAAGG-3Ј; Fiber19aR, 5Ј-TTATGAATTCTGGTCTTTCATTCTTGGGC-3Ј). The Ad5 knob expression plasmid pTrcK5 was generated by PCR amplification of the fiber gene region encoding the knob domain, using forward and reverse primers containing nonhybridizing EcoRI and BclI restriction site sequences (Knob5F, 5Ј-CAATGAT-CATGGCCTAGAATTTGAT-3Ј; Knob5R, 5Ј-ATAGAATTCC-TATTCTTGGGCAATGTATG-3Ј). The Ad19a fiber transfer plasmid pTrcFib19a was generated by PCR amplification of the Ad19a fiber gene region, using primer Fiber19aF (5Ј-ATATG-GATCCAATGTCAAAGAGGCTCCG-3Ј) and primer Fiber19aR. The PCR products were purified, cut with the corresponding restriction enzymes, and ligated to EcoRI-and BamHI-cleaved pTrcHis2B (Invitrogen Life Technologies). For recombinant expression of knob proteins, Escherichia coli BL21 (Stratagene, La Jolla, CA) was transformed with plasmids pTrcKnob5 and pTrcKnob19a, respectively, and protein expression was induced with isopropyl ␤-D-thiogalactopyranoside (Sigma). Knob proteins carrying a 6ϫHis tag at the N terminus were affinity purified with Ni 2ϩ -NTA agarose (Qiagen) as previously described (Volpers et al., 2003) . The purity of the protein preparation was controlled by separation of the proteins by sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) followed by silver staining (Blum et al., 1987) .
RESULTS
The Ad19a vector transduces human myoblasts with high efficiency
The ability of Ad19aEGFP and Ad5EGFP to transduce myoblasts, including immortalized primary mouse myoblasts, primary fetal pig myoblasts, primary rhesus monkey myoblasts, and primary fetal human myoblasts (FHMs), was compared. Cells were transduced overnight with 1250, 2500, and 12,500 vector particles per cell (VP/cell), respectively. Forty-eight hours later the efficiency of transduction was quantitatively assessed by determining the fraction of cells expressing GFP, using flow cytometry (FACS) ( Table 1 ). In general, transduction efficiencies of Ad5 for the nonhuman species, ape, pig, and mouse, were higher than that of Ad19aEGFP. An average of 70.7% of ape myoblasts were GFP positive when transduced with 1250 VP of Ad5 per cell, compared with 13.5% when transduced with Ad19a. Efficient transduction (39.8%) of mouse myoblasts by Ad5 was observed only at the highest vector dose used (12,500 VP/cell), whereas Ad19a transduced only 5.8% of mouse myoblasts with the same vector dose. In contrast, human myoblasts were transduced much more efficiently by the Ad19a vector than by the Ad5 vector. Even at the lowest vector dose (1250 VP/cell) more than 90% of human myoblasts expressed GFP, whereas only 43% of the myoblasts transduced with Ad5 were GFP positive.
Quantification of the transduction of skeletal muscle cells from different species
To address the question as to whether the observed differences in transduction (FACS data) among myoblasts of various species were due to differences in gene expression levels or to differing transduction efficiencies, the amount of cell-associated adenovirus genomes was compared with transgene expression. Primary myoblasts originating from different species and rat L6 myoblasts were transduced in the same way as described above and EGFP expression was quantified with a fluorescence multiwell reader after 48 hr. In addition, cell-associated adenovirus DNA was isolated from the same experiment and quantified by quantitative real-time PCR. Transgene expression in transduced myoblasts was already high at 24 hr (data not shown) and reached its maximum by 48 hr. Corresponding pictures of GFP-expressing myoblasts transduced with 12,500 VP/cell were taken at that time point (Fig. 1B) . Confirming the FACS data, the highest transgene expression in cells transduced with Ad5EGFP was measured in ape myoblasts, followed by pig, human, mouse, and L6 rat myoblasts. The highest transgene expression in Ad19aEGFP-transduced cells was measured in human myoblasts, followed by, in decreasing order, ape, pig, and mouse myoblasts (Fig. 1A) . Transgene expression in rat L6 cells was too low to be quantified. Quantitative real-time PCR of cell-associated vector particles revealed that the genomic copy number in transduced cells correlated well with transgene expression (Fig. 2) . In transduced human, ape, pig, and mouse myoblasts the amount of cell-associated vector particles increased proportionally to the vector doses used (Table 2) . We observed particularly efficient transduction of primary human myoblasts by Ad19aEGFP. Up to 6.59% of the initially applied vector particles (1250 VP of Ad19aEGFP per cell) were detected in human myoblasts, whereas an average of only 0.1% Ad5EGFP genomes was present at this dose. The number of Ad19aEGFP vector genomes detected was 30-to 68.7-fold higher as compared with the corresponding Ad5EGFP. This was mirrored by 7-to 78-fold (depending on the vector particles applied per cell) higher transgene expression (Table 2 ). Both types of vectors only poorly transduced rat L6 and primary mouse myoblasts. In ape myoblasts an interesting difference between the two vectors was noted: whereas the total number of cell-associated Ad19a vector particles was 2.9-fold higher than Ad5EGFP in ape myoblasts transduced with 12,500 VP/cell, THIRION ET AL. 4 transgene expression per Ad19aEGFP vector genome was 6.6-fold lower than that of Ad5EGFP. These differences in transgene expression efficiency are reflected by the particle per measured relative light unit ratio, which in this case was 26-fold (2500 VP/cell) and 20-fold smaller (12,500 VP/cell) for Ad19aEGFP, respectively, as compared with Ad5EGFP. Similarly, higher amounts of Ad19aEGFP vector particles (2.7-fold) accumulated in pig myoblasts transduced with 12,500 VP/cell without a corresponding increase in transgene expression (Fig.  2) . This points to a differential regulation of the promoters in the different species.
Maturation-independent transduction of human myotubes by Ad19a
Myoblasts are able to differentiate in vitro and form multinucleated myotubes, which are difficult to transduce with Ad5-based vectors. To investigate whether the higher transduction efficiency of human myoblasts by Ad19a extends to myotubes, human and ape myotubes were transduced with both vectors. Subsequently, GFP expression was quantified and corresponding pictures of GFP-expressing myotubes transduced with 12,500 VP/cell were taken at that time point (Fig. 3A and B) . Consistent with previously reported data, Ad5EGFP transduced human myotubes less efficiently than myoblasts (Acsadi et al., 1994) . At the highest vector dose the relative amount of Ad5EGFP vector genomes detected per transduced well (12,500 VP/cell) was 4.4-fold lower in human myotubes than in myoblasts and resulted in drastically reduced transgene expression (5.7% of that seen in myoblasts; Table 3 ). Compared with human myotubes transduced with Ad5EGFP at 12,500 VP/cell, transgene expression was 100-fold higher in ape myotubes transduced with the same vector dose. The increase in transgene expression correlated with a 17-fold increase in cell-associated Ad5EGFP vector particles in ape myotubes relative to human myotubes ( Fig. 3 and Table 3 ). These data indicate that ape myotubes are more susceptible to Ad5 transduction than are human myotubes.
A similar reduction of transgene expression in human myotubes versus myoblasts was observed for Ad19aEGFP. With 12,500 VP/cell applied, transgene expression efficiency reached 14.3% of that seen after transduction of myoblasts. Compared with Ad5EGFP, however, transgene expression by Ad19aEGFP was 19-fold higher, correlating with a 13-fold higher amount of cell-associated Ad19aEGFP vector particles (Fig. 3C and D and Table 3 ). Similar to the situation in ape myoblasts, GFP expression per cell-associated Ad19aEGFP vector particle in ape myotubes was less efficient (Fig. 3C and D and Table 3 ). The Ad19aEGFP particle per relative light unit ratio was 11-fold (12,500 VP/cell) higher for Ad19aEGFP as compared with Ad5EGFP at the same vector dose.
More than one receptor is involved in attachment of Ad5 to human muscle cells
The classic pathway for binding and uptake of Ad5 to cells involves binding to CAR followed by virus uptake on interaction with its secondary receptors, ␣ v ␤ 3 and ␣ v ␤ 5 integrins (Wickham et al., 1993; Nemerow, 2000) . More recently, additional receptors such as heparan sulfate proteoglycans (HSPGs) were suggested to contribute to Ad5 attachment as well (Dechecchi et al., 2000 (Dechecchi et al., , 2001 . To determine whether these receptors are also involved in attachment of Ad5 to FHMs, cells were treated with various reagents known to interfere with binding of Ad5 to cellular attachment and internalization receptors. Interaction of Ad5 with its primary receptor, CAR, can be inhibited with purified fiber knob protein, attachment to the secondary receptors ␣ v ␤ 3 and ␣ v ␤ 5 can be inhibited with soluble GRGDS peptide (Wickham et al., 1993) , whereas heparin can be used to compete with Ad5 for binding to HSPGs. The inhibitory effect of these reagents was assessed by their ability to compete for binding and internalization of a first-generation adenovirus vector expressing ␤-galactosidase (AdFZ␤Gal). Cells 
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were treated with purified recombinant Ad5 knob protein, GRGDS peptide, and heparin, or with combinations thereof. Initially, optimal working concentrations were determined for each substance at 4 and 37°C, respectively. Optimal inhibitory activity of attachment of Ad5 to FHMs occurred at concentrations of 10 g of heparin per milliliter, 2 mM GRGDS peptide, and 10 g of knob protein per milliliter, respectively, at both temperatures (data not shown). Incubation of FHMs with heparin or knob at 4°C reduced transgene expression by ϳ60%, whereas addition of GRGDS alone had little effect. Additive effects were observed when knob protein was combined with heparin, but not when combined with GRGDS peptide at 4°C. Coaddition of knob and heparin reduced transgene expression by 80% (Fig. 4A) . This is consistent with the idea that both Abbreviations: FHM, fetal human myoblasts; MT, myotube; Q-PCR, quantitative polymerase chain reaction; RFU, relative fluorescence unit; VG, vector genome; VP, vector particle.
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heparin-and knob-binding CAR receptors, but not integrins, are involved in initial virus attachment. The results also suggest that heparin and knob target independent receptor entities. Adding GRGDS peptide to knob did not further decrease binding at 4°C, which is in accordance with the proposed role of integrins in internalization but not attachment.
To investigate the effect of these agents on vector internalization, cells were preincubated for 1 hr at 4°C with competing substances and vector was added for 1 hr at 37°C. Under these conditions the addition of knob protein or heparin alone reduced transgene expression by ϳ40%, whereas competition with GRGDS peptide alone decreased transgene expression by 25%. Additive effects confirmed the inhibitory action of GRGDS on virus uptake. Transgene expression was decreased by 66 and 60% when GRGDS was combined with knob protein and heparin, respectively (Fig. 4B) . These results are in agreement with the proposed two-step model for Ad5 infection (Wickham et al., 1993; Bergelson et al., 1997; Tomko et al., 1997) , and extend findings suggesting a role for HSPGs in cell attachment of Ad5 (Dechecchi et al., 2000 (Dechecchi et al., , 2001 . Myotubes behaved similar to myoblasts. Binding of Ad5 to myotubes was sensitive to knob protein and heparin, but not to GRGDS peptide, whereas internalization was sensitive to knob protein and soluble GRGDS peptide (data not shown).
Ad19a attaches to a sialic acid-containing receptor on human myoblasts
To determine whether the increased efficiency of Ad19a over Ad5 to transduce human myoblasts was related to differential receptor usage, FHMs were pretreated with various competing agents at 4°C before Ad19a binding. The inhibitory effect of these reagents was assessed by their ability to compete for binding and internalization of Ad19aEGFP. Transgene expression was quantified 48 hr posttransduction by means of fluorescence measurement. As expected, attachment was not significantly affected by treatment with GRGDS peptide (Fig. 5A) . However, in contrast to Ad5, binding of Ad19a was also not blocked by heparin. Recombinant Ad19a knob protein expressed in E. coli was not able to inhibit binding of Ad19aEGFP at concentrations up to 10 g/ml (data not shown), but showed inhibiting activity (Ͼ80%) at high protein concentration (100 g/ml) (Fig. 5A) . To determine if attachment of Ad19a occurred through fiber-cell interactions, also full-length Ad19a fiber protein was expressed in insect cells and affinity-purified. Treatment of FHMs with 10 g/ml recombinant fiber protein decreased vector attachment by 79 Ϯ 2% and was able to block virus attachment completely (97 Ϯ 2%) at higher concentrations (50 g/ml) (data not shown). This result clearly demonstrates that attachment of Ad19a to FHMs is indeed mediated by its fiber protein.
As it was previously reported that attachment and uptake of Ad19a depended on binding to sialic acid, the latter was removed from the cell surface by treatment with neuraminidase (1 hr at 37°C). This treatment completely abolished attachment of Ad19aEGFP to FHM cells (Ͼ95%). The same complete inhibition was seen on incubation with wheat germ agglutinin (Fig. 5A) . Wheat germ agglutinin (WGA) binds specifically to N-acetyl-␤-(1,4) -D-glucosamine carbohydrate moieties that might be part of the epitope recognized by Ad19a. Neuraminidase and WGA pretreatments did not affect attachment of Ad5 to FHM cells (data not shown). Next, we investigated which factors were involved in Ad19a uptake. FHMs were preincubated with competing reagents for 1 hr at 4°C, followed by addition of vector for 1 hr at 37°C (Fig. 5B) . As for Ad5, incubation with GRGDS peptide resulted in a moderate reduction of transgene expression (by 34%). Interestingly, heparin, which did not interfere with virus binding at 4°C, showed significant inhibitory activity at 37°C (ϳ50% reduction). Prein- cubation with a combination of heparin and GRGDS peptide further decreased transgene expression in an additive way (74% reduction). Transduction of myoblasts at 37°C still was highly sensitive to WGA and neuraminidase, resulting in Ͼ95% inhibition of GFP expression (Fig. 5B) . Taken together, our data clearly indicate a different mechanism for attachment and uptake of Ad5-and Ad19a-based vectors, which may form the basis for the various transduction efficiencies seen in myoblasts of different species.
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DISCUSSION
With the intention to exploit the natural tropism of the various adenoviruses we have established a new vector for gene therapy and vaccination based on the subgroup D adenovirus type 19a (Ruzsics et al., manuscript in preparation) . Here we have compared the efficiency of transduction of myoblasts and myotubes of various species by this novel Ad19a-derived vector with that achieved by the most commonly used adenovirus Ad5 vector. The adenovirus type 19a vector transduced primary human myoblasts, and otherwise difficult-to-transduce human myotubes, much more efficiently than the corresponding Ad5-based vector. Quantitative transduction of primary human myoblasts as measured by GFP expression was achieved even when Ad19a at only 1250 VP/cell was used (Table 1 and Fig. 1B) . Accordingly, the fraction of vector genomes taken up into human myoblasts was relatively high. Up to 6.6% of the initially applied vector genomes were detected at 48 hr by real-time PCR in primary human myoblasts transduced with 1250 VP/cell. By contrast, only 0.1% of Ad5 genomes were detected in the same experiment. In comparison with Ad5 the number of vector genomes per cell was 30-to 68-fold higher and correlated with enhanced transgene expression, which was 7.6-to 78-fold higher depending on the amount of input vector. Although in differentiated human myotubes transduction was considerably lower, the decrease in efficiency was less pronounced for the Ad19a vector than for the Ad5 vector. For Ad19a and Ad5 the fluorescence detected was 14.3 and 5.7% (at 12,500 VP/cell input) of that seen with human myoblasts. At the same input level, human myotubes contained 11.5-fold more Ad19a genomes than Ad5 genomes.
Both vectors showed low transduction of primary mouse and rat L6 myoblasts, whereas the efficiency was reversed in pig and monkey myoblasts and myotubes. In these species Ad5-mediated transgene expression was much more efficient than that mediated by Ad19a and correlated with the vector genomes taken up. A particularly drastic difference in transgene expression was observed in ape myotubes. Whereas there was only a 1.7-fold higher amount of Ad5 vector genomes as compared with Ad19a genomes, the expression level of the Ad5 transgene was 18-fold higher than that of Ad19a. Thus intrinsic differences in vector transfer and transgene expression seem to exist between Ad5 and Ad19a, which both contribute to efficient transduction.
Similar species-dependent variations in gene transfer efficiency were observed in a dose-response study with smooth muscle cells (SMCs) derived from carotid arteries of various species (Havenga et al., 2002) . In this and our own study, Ad5 exhibited relatively high transduction efficiency for primate-derived cells, indicating that Ad5 might well be adapted to this species. Quantification of cell-associated viral particle numbers in transduced myoblasts of various species revealed two putative barriers for adenoviral transduction. In mouse and rat L6 myoblasts an early block may occur at the level of vector attachment or internalization; here, the low transgene expression correlated well with low amounts of Ad5 and Ad19a vector particles. For Ad19a vectors, a postinternalization block of GFP expression may be postulated in ape and possibly also in pig myoblasts, where high numbers of cell-associated Ad19aEGFP vector particles accumulated without a corresponding increase in GFP expression. Differences in attachment, internalization, intracellular trafficking, and promoter regulation of both vectors may thus exist among myoblasts of various species. This highlights the problem of using nonhuman species as models for in vivo testing of vector efficacies. Obviously, transduction efficiency by viral vectors cannot be correctly predicted for the human situation on the basis of experiments with rodent cells. The same may be true for animal experiments and requires further investigation.
Differential activities of the viral enhancer and promoter elements inserted in Ad19a versus Ad5 may explain the inefficient GFP expression in ape and pig myoblasts transduced with Ad19aEGFP (Yoshida et al., 1995) . Also, a differential effect by E4 proteins must be considered, because leaky expression in first-generation vectors occurs and has been reported to influence transgene expression controlled by the CMV promoter (Gorziglia et al., 1999; Lusky et al., 1999) . Moreover, the Ad5 viral E1 enhancer, which influences transgene expression from expression cassettes incorporated into the E1 region, may not function equally well in the different species (Yoshida et al., 1995) . It is not known at present whether a similar enhancer element is conserved in Ad19a E1.
The differential capacity of both vectors to transduce human myoblasts appears to be due to differential receptor usage. A combination of heparin and knob was necessary to efficiently inhibit binding of Ad5 to primary human myoblasts. Soluble GRGDS peptide, an inhibitor of ␣ v ␤ 3 integrin function, had no effect on vector binding but affected transduction at 37°C, confirming that ␣ v ␤ 3 is involved in virus internalization rather than in virus binding (Wickham et al., 1993; Nemerow, 2000) . In agreement with the proposed two-step model for Ad5 cell transduction, additive inhibitory effects of GRGDS peptide combined with knob and heparin, respectively, were observed at 37°C but not at 4°C, a temperature nonpermissive for virus internalization (Wickham et al., 1993; Bergelson et al., 1997) . Taken together these results are consistent with previous findings, while also demonstrating the importance of alternative receptors such as heparan sulfate proteoglycans for Ad5 binding and transduction of human muscle cells Dechecchi et al., 2000 Dechecchi et al., , 2001 . Mutation of the putative heparan sulfate-binding motif KKTK within the Ad5 fiber shaft led to drastic liver detargeting in C57BL/6 mice as well as in nonhuman primates. Importantly, however, the same mutant displayed clear strain and species differences in the host response in mice and rats (Nicklin et al., 2005) . Soluble GRGDS peptide also had no effect on Ad19a vector binding, but reduced the transduction efficiency at 37°C, suggesting that ␣ v integrins are also involved in uptake of Ad19a. This is supported by previous data and is compatible with the presence of a conserved putative integrin-binding RGD motif within the Ad19a penton base protein (Arnberg et al., 2000b) . In contrast to Ad5, attachment of Ad19a vector to FHMs at 4°C was completely blocked by WGA and ␣(2,3)-specific neuraminidase treatment. Therefore, Ad19a may specifically recognize a carbohydrate epitope containing ␣(2,3)-linked sialic acid and the sugar moiety recognized by WGA, N-acetyl-␤-(1,4)-D-glucosamine. This finding is in accordance with previously published data showing that attachment of Ad19a to A549 cells was sensitive to neuraminidase treatment (Arnberg et al., 2000b) . However, other reports suggest that Ad37, a virus with a fiber identical to that of Ad19a, binds to CD46 in a sialic acid-independent and calcium-dependent way (Wu et al., 2001 (Wu et al., , 2004 . Further experiments are required to determine whether CD46 is involved in the attachment of Ad19a to muscle cells. Heparin did not interfere with binding of Ad19a to muscle cells at 4°C, but reduced gene transfer efficiency in a cooperative way with GRGDS peptide at 37°C. A role for heparin-binding receptors in Ad19a internalization has not been reported so far. It is possible that heparin and GRGDS bind to different putative coreceptors important for internalization. Alternatively, heparin may have a differential effect on intracellular trafficking of the two viruses. At present, these results support a two-step model for Ad19a, similar to Ad5, with separate receptors involved in virus binding and uptake. Together, our data support the view that Ad19a binds to myoblasts in a sialic acid-dependent fashion on which a differential delivery pathway as compared with Ad5 may be chosen.
The tropism of one adenoviral serotype can be transferred, at least in part, from one serotype to another by swapping the entire fiber molecules or the distal fiber knob domains. Systematic analysis of serum antibodies led to the construction of fiber-chimeric Ad5-based vectors (Ad5.Fib16, Ad5.Fib35, and Ad5.Fib50), which showed enhanced transduction of human primary cells and established cancer cell lines (Knaan-Shanzer et al., 2001; Rea et al., 2001; Havenga et al., 2002) . A pseudotyped Ad5 vector (Ad5.Fib37) displaying the Ad37 fiber, which is identical to the Ad19a fiber, also showed modified tropism with partial liver detargeting in rats (Denby et al., 2004) . Differential binding, deviating expression profiles, or posttranslational modifications of putative entry receptors (CAR, sialic acid, CD46) might be among the causative factors explaining interspecies differences (Bergelson et al., 1997; Tomko et al., 1997; Suzuki et al., 2000; Inoue et al., 2003) . As an example, expression of CD46 is restricted to testis in mice, whereas expression in humans is broad (Inoue et al., 2003) .
In this study we demonstrated that the novel Ad19a serotype vector was particularly well suited for transduction of human muscle cells. In addition, the Ad19a vector also seems promising for targeting lymphoid cells and tumors, and therefore should be useful for cancer gene therapy (Ruzsics et al., manuscript in preparation) . Low pre-existing immunity against Ad19a in the human population should make this new vector more suitable for vaccination and gene transfer applications than Ad5 vectors pseudotyped with the corresponding subgroup D fibers.
Careful monitoring of transduction data revealed that it may be useful to complement gene expression and FACS data with a quantitative assessment of transduced viral genomes in order to compare vector transduction efficiencies, especially in different species. This makes it possible to distinguish speciesspecific effects on vector uptake from any species-specific influence on transgene expression. Similar in vivo testing of adenoviral serotype vectors in various animal models may eventually help to find the animal model most similar to humans, and help to better translate results from the animal model to humans.
